DAN J. MITCHELL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2014-04-15 Mr. Mitchell founded and is a manager of Sequel Venture Partners, L.L.C., a venture capital firm formed in January 1997.
2015-04-14 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. Mr. Mitchell is an appropriate member of the Company’s Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.
2016-04-27 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.
2017-04-21 Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.
2018-04-18 Mr. Mitchell founded Sequel Venture Partners, a venture capital firm, and has expertise in pharmaceutical industry and corporate finance. He holds a B.S. and an M.B.A. but no mention of computer science or programming.
2018-09-20 Dan J. Mitchell is listed as a director, no software-related background indicated.
2019-10-25 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. He has expertise in pharmaceutical industry and corporate finance.
2020-10-28 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. We believe Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.
2021-04-21 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. We believe Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.
2022-11-03 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. He has experience in venture capital and pharmaceutical industry finance.
2023-12-19 Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. We believe Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance.

Data sourced from SEC filings. Last updated: 2025-10-11